Poor medication adherence in diabetes: What's the problem?

Journal of Diabetes

Volumn 7, Issue 6, 2015, Pages 777-778

  Polonsky, William H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; ANTIDIABETIC AGENT;

BEHAVIOR; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DRUG COST; EDUCATION; HEALTH BELIEF; HEALTH CARE COST; HOSPITALIZATION; HUMAN; KNOWLEDGE; MORTALITY; NOTE; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK REDUCTION; SELF CARE; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ECONOMICS; FEMALE; HYPERGLYCEMIA; HYPOGLYCEMIA; MALE; MEDICATION COMPLIANCE; PSYCHOLOGY;

ASIAN CONTINENTAL ANCESTRY GROUP; DEPRESSION; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DRUG COSTS; FEMALE; HEALTH EXPENDITURES; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; MALE; MEDICATION ADHERENCE;

EID: 84944676982     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12306     Document Type: Note

References (13)

1. Krass I, Schieback P, Dhippayom T. Adherence to diabetes medication: A systematic review. Diabet Med. 2014; 32: 725-737. doi:10.1111/dme.12651.
2. Egede LE, Gebregziabher M, Echols C, Lynch CP. Longitudinal effects of medication nonadherence on glycemic control. Ann Pharmacother. 2014; 48: 562-570.
3. Casagrande R, Fradkin JE, Saydah SH, Rust KF, Cowie C. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes Care. 2013; 36: 2271-2279.
4. Zhang Y, Ting RZW, Yang W etal. Depression in Chinese patients with type 2 diabetes: Associations with hyperglycemia, hypoglycemia, and poor treatment adherence. J Diabetes. 2015; 7: 800-808.
5. Gonzalez JS, Peyrot M, McCarl LA etal. Depression and diabetes treatment nonadherence: A meta-analysis. Diabetes Care. 2008; 31: 2398-2403.
6. Fisher L, Gonzalez JS, Polonsky WH. The confusing tale of depression and distress in patients with diabetes: A call for greater clarity and precision. Diabet Med. 2014; 31: 764-772.
7. Larkin AT, Hoffman C, Stevens A, Douglas A, Bloomgarden Z. Determinants of adherence to diabetes treatment. J Diabetes. 2015; 7: 864-871.
8. Kerse N, Buetow S, Mainous AG 3rd, Young G, Coster G, Arroll B. Physician-patient relationship and medication compliance: A primary care investigation. Ann Fam Med. 2004; 2: 455-461.
9. Ratanawongsa N, Karter AJ, Parker MM etal. Communication and medication refill adherence: The Diabetes Study of Northern California. JAMA Intern Med. 2013; 173: 210-218.
10. Miller GE, Sarpong EM, Hill SC. Does increased adherence to medications change health care financial burdens for adults with diabetes? J Diabetes. 2015; 7: 872-880.
11. Horne R, Chapman SC, Parham R, Freemantle N, Forbes A, Cooper V. Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: A meta-analytic review of the Necessity-Concerns Framework. PLoS ONE. 2013; 8: e80633. doi:10.1371/journal.pone.0080633.
12. Sapkota S, Brien JA, Greenfield J, Aslani P. A systematic review of interventions addressing adherence to anti-diabetic medications in patients with type 2 diabetes: Impact on adherence. PLoS ONE. 2015; 10: e0118296.
13. Rosenbaum L. Beyond belief: How people feel about taking medications for heart disease. N Engl J Med. 2015; 372: 183-187. doi:10.1056/NEJMms1409015.